How doctors actually work (Praxis ≠ hospital ≠ other markets)
Praxis
Outpatient, time-constrained, efficiency-driven
Hospital
Hierarchical, protocol-heavy
International market entry
Your healthtech will fail in Germany.
Unless it fits how the system actually works.
We help international healthtech companies adapt their product, compliance, and go-to-market to succeed in Germany.
Trusted by teams navigating hospital workflows, procurement reality, and clinical adoption.
The real problem
It’snotyourproduct.
The uncomfortable part is rarely the roadmap. It’s the gap between what you shipped and how care is actually delivered, bought, documented, and reimbursed in Germany—and how unlike that is from the markets you already won.
How liability, documentation, and data rules bind the product in practice
GDPR is table stakes; clinical liability and audit trails shape what “safe to use” means on the floor.
How procurement and hospital IT actually buy—and how slowly consensus forms
Framework agreements, security reviews, and parallel paper workflows eat timelines you didn’t model.
What counts as proof to German payers, Kliniken, and frontline staff
Pilot novelty ≠ durable utility. Evidence has to read credible in local clinical and economic language.
Why “it worked elsewhere” quietly breaks at the German bedside
Workflow density, documentation load, and fragmented systems change what adoption requires.
Germany is not a market.
It’s a system.
What we do
We make your product work in Germany.
- Not strategy slides.
- Not generic consulting.
- Not decks no one owns after the workshop.
We go into your product, challenge your assumptions, rebuild go-to-market, and ground it all in how the German healthcare system actually works—not the template that worked elsewhere.
What we deliver
Services
Three ways we help you align product, compliance, and traction with how Germany actually works.
Market Reality Check
Should you even enter Germany?
- Market viability assessment
- Competitive landscape
- Regulatory blockers
- Reimbursement potential (e.g. DiGA suitability)
Outcome: clear go / no-go + risk map
Product Adaptation Blueprint
What must change for your product to work in Germany
- Clinical workflow alignment (Praxis, MVZ, hospital use)
- Feature gaps vs German expectations
- Localization beyond language
- Compliance gaps (MDR, GDPR)
Outcome: actionable product roadmap for Germany
Go-To-Market & Partnerships
How to get your first traction in Germany
- Target customer definition
- Provider strategy (clinics, doctors, networks)
- Pilot and entry strategy
- Partnership mapping
Outcome: clear path to first customers and pilots
Anna Solovyova
Healthtech & AI executive
- 10+ years in healthtech and AI leadership
- Built and scaled startups; AI programs across 40+ diagnostic labs
- Clinical validation, MDR, and GDPR in live execution
About the founder
Built inside clinical reality.
Medora was built from real experience inside the German healthcare system.
Founded by Anna Solovyova, a healthtech and AI executive with 10+ years of experience, Medora brings together product, clinical, and regulatory expertise — not in theory, but in execution.
From building and scaling healthtech startups, to leading AI programs across 40+ diagnostic laboratories, to designing clinical validation and compliance under MDR and GDPR — this is work done inside the system, not around it.
Medora applies this experience to one problem most teams underestimate:
Why products don’t get adopted — even when they are approved, funded, and launched.
If Germany is on your roadmap — don’t guess.
Most companies waste months.
Some waste years.
You don’t have to.
30 min. No pitch. Just clarity.
Contact
Start the conversation
Brief context is enough. We respond personally.